LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionManuela Mura, Sarah P. Blagden, Normala Abd Latip et al.|Oncogene|2014Cited by 152
Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluationT.G. Hopkins, Sarah P. Blagden, Chara Stavraka et al.|Climacteric|2014Cited by 41
ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors.Essam Ghazaly, Sarah P. Blagden, Christopher McGuigan et al.|Journal of Clinical Oncology|2013Cited by 8
The RNA-binding protein LARP1 as potential biomarker and therapeutic target in ovarian cancerT.G. Hopkins|Spiral (Imperial College London)|2014Cited by 0